Study open


The purpose of this study is to demonstrate the safety and efficacy of this product to prevent COVID 19. These results were already shown by previous studies with a small target group. This study will include the group between 12 and 18 years of age. The two active vaccines will be compared with each other in combination with a minimal placebo group. Would you like to help science also strengthen people with impaired immunity in fighting COVID-19?
At Anima, each study is preceded by a screening interview where you will have the opportunity to discuss with the doctor any further questions or uncertainties in a discreet manner.

Participation in the study

  • 95% chance of getting one of the 2 variants administered
  • <5 % kans dat je een placebo krijgt

Sign up


  • Are you a boy/girl older than 12 years (weigh more than 40kg)
  • Are you a male/female over 18 years of age
  • Do you have immunity problems owing to your cancer treatment, transplants, rheumatism, psoriasis, ...


  • The study lasts a maximum of 12 months
  • You will need to come to the study center at least 11 times during this period.
  • There will be a weekly follow-up by phone or email


Anima Research Center
Alkerstraat 32Z (Block D)
3570 Alken


You will receive a fee to compensate for the time and actions.